AMDL Announces Launch Of Antibiotic Levofloxacin In China

Sat, 18 Nov 2006 02:00 PM EST

... AMDL (Amex: ADL) announced today that its China subsidiary, Jade Pharmaceutical Inc., has received approval from the China State Food and Drug Administration (SFDA) for the antibiotic levofloxacin. Levofloxacin is used to treat infections including pneumonia, urinary tract, kidney and skin infection. It is in a class of antibiotics called fluoroquinolones. [click link for full article] ...